Migraine with aura is a subtype in which the headache is preceded or accompanied by reversible neurological disturbances—visual (scotomas, zigzags), sensory, or speech-related—lasting between 5 and 60 minutes; it carries an added cardiovascular risk and… Read more.
2 factors with evidence, ordered from most to least effective. Information, not medical advice.
⏱ 2 min read
Migraine with aura is a subtype in which the headache is preceded or accompanied by reversible neurological disturbances —visual (scotomas, zigzags), sensory, or speech-related— lasting between 5 and 60 minutes; it carries an added cardiovascular risk and calls for specific precautions with hormonal contraceptives.
Migraine with aura is associated with an increased risk of ischemic stroke, especially in women who take combined contraceptives or smoke. For this reason, guidelines (WHO, CDC) contraindicate combined estrogens in women with migraine with aura: the alternative is progestin-only methods.
Meta-analyses on migraine prophylaxis typically do not separate the with-aura subtype from the without-aura subtype; the prophylactic effect of supplements is extrapolated.
Magnesium: Grade A · 3 trials · 180 participants: moderate reduction in migraine frequency. Dose: 400-600 mg/day. Severity: small effect (Grade B). Duration: no effect (Grade D). Suggested form: glycinate or malate.
Riboflavin (vitamin B2): Grade B · 4 trials · 180 participants: small reduction in frequency and duration. Severity does not change. Dose: 400 mg/day. Noticeable at 2-3 months.
Coenzyme Q10: Grade D for migraine frequency, duration, and severity. No consistent effect.
Treatment of attacks: specific triptans (sumatriptan, rizatriptan) or gepants during attacks. Pharmacological prophylaxis: topiramate, propranolol, candesartan, amitriptyline, anti-CGRP antibodies (erenumab, fremanezumab, galcanezumab) in refractory cases. Decision by neurology.
Estrogen-containing combined contraceptives in women with migraine with aura (stroke risk). Tobacco (multiplies the risk). Identified personal triggers: stress, dehydration, prolonged fasting, red wine, aged cheeses depending on the person.
Yes (prophylaxis with supplements): magnesium (best evidence) and riboflavin as reasonable adjuncts, especially in frequent migraine. Low cost and good tolerability.
No: expecting a single supplement to replace medical treatment in frequent or disabling migraine. Migraine with aura deserves a neurological evaluation.
Migraine with aura shares its prophylaxis with migraine without aura: magnesium (Grade A) and riboflavin (Grade B) have reasonable support; CoQ10 does NOT. What distinguishes the with-aura subtype is the added cardiovascular risk and the contraindication of combined estrogens. Comprehensive treatment with a neurologist: identify triggers, treat attacks, and consider pharmacological prophylaxis if attacks are frequent.
⏱ 2 min read
Migraine with aura is a subtype in which the headache is preceded or accompanied by reversible neurological disturbances —visual (scotomas, zigzags), sensory, or speech-related— lasting between 5 and 60 minutes; it carries an added cardiovascular risk and calls for specific precautions with hormonal contraceptives.
Migraine with aura is associated with an increased risk of ischemic stroke, especially in women who take combined contraceptives or smoke. For this reason, guidelines (WHO, CDC) contraindicate combined estrogens in women with migraine with aura: the alternative is progestin-only methods.
Meta-analyses on migraine prophylaxis typically do not separate the with-aura subtype from the without-aura subtype; the prophylactic effect of supplements is extrapolated.
Magnesium: Grade A · 3 trials · 180 participants: moderate reduction in migraine frequency. Dose: 400-600 mg/day. Severity: small effect (Grade B). Duration: no effect (Grade D). Suggested form: glycinate or malate.
Riboflavin (vitamin B2): Grade B · 4 trials · 180 participants: small reduction in frequency and duration. Severity does not change. Dose: 400 mg/day. Noticeable at 2-3 months.
Coenzyme Q10: Grade D for migraine frequency, duration, and severity. No consistent effect.
Treatment of attacks: specific triptans (sumatriptan, rizatriptan) or gepants during attacks. Pharmacological prophylaxis: topiramate, propranolol, candesartan, amitriptyline, anti-CGRP antibodies (erenumab, fremanezumab, galcanezumab) in refractory cases. Decision by neurology.
Estrogen-containing combined contraceptives in women with migraine with aura (stroke risk). Tobacco (multiplies the risk). Identified personal triggers: stress, dehydration, prolonged fasting, red wine, aged cheeses depending on the person.
Yes (prophylaxis with supplements): magnesium (best evidence) and riboflavin as reasonable adjuncts, especially in frequent migraine. Low cost and good tolerability.
No: expecting a single supplement to replace medical treatment in frequent or disabling migraine. Migraine with aura deserves a neurological evaluation.
Migraine with aura shares its prophylaxis with migraine without aura: magnesium (Grade A) and riboflavin (Grade B) have reasonable support; CoQ10 does NOT. What distinguishes the with-aura subtype is the added cardiovascular risk and the contraindication of combined estrogens. Comprehensive treatment with a neurologist: identify triggers, treat attacks, and consider pharmacological prophylaxis if attacks are frequent.